Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Biotec Pharmacon presentation - Christian Jorgensen, CEO, Biotec Pharmacon A
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Biotec Pharmacon presentation
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Bittium Q2 8.8.19 | Hannu Huttunen, CEO, Bittium OyjBITTI:HEX
00:10:00
William Higgons: "We are acquiring Catana, Sii, and Séché Environnement."
00:10:00
Westhaven Gold Corp: Achievements and Future Goals in the Spences Bridge Gold Belt
00:10:00
Geopacific Resources (ASX:GPR) CEO Tim Richards addresses delays in commissioning at Woodlark Gold Mine in Papua New Guinea, with focus on rectifying issues related to the island's wharf for the upcoming project's first gold pour expected in early 2023.|J
00:10:00
Dynamic Mining Showcases Low-Capex Guinea Bauxite Project at One-to-One Conference
00:10:00
"Empowering Creativity: Oscar Höglund's Vision for the Music Industry"
00:10:00
Introducing Bast Gate's New Wireless Sensors: Simplified Setup and Customizable Solutions
00:10:00
Core Tin's Strategic Role in Securing UK Tin Supply Amid Global Shortages
00:10:00
FBN, a unit of FOX News Media with bureaus in Chicago, discusses Rumble's view that Twitter caused 'the worst, most egregious' implications.
00:10:00
The invariant subspace method was applied to the study of continuous-time quantum walk (CTQW)|Chen-Fu Chiang,Quantum technologies
00:10:00
PYX Resources CEO Highlights Sustainability Efforts and Premium Zircon Operations | Oliver Hasler, Chairman , PYX Resources Ltd.
00:10:00
Chiome Bioscience leverages cutting-edge antibody technology for drug discovery and development| Shigeru Kobayashi,CEO, Chiome Bioscience Inc.